The US biosimilar market: Predictions for 2021
pharmaphorum
JANUARY 28, 2021
At the same time, the average cost of insulin for patients per year almost doubled from $2,864 to $5,705 between 2012 and 2016. Pharmacists have more insight into a patient’s insurance coverage than most providers, so this change could create a lot of value for patients throughout the country.
Let's personalize your content